Building on a traditional banking apprenticeship, Matthias Schomber qualified as a certified stockbroker and Eurex trader. In the years that followed, he deepened his expertise in proprietary trading at renowned banks and financial services firms, where he specialized in the dynamic trading of stocks, options, and futures. This solid practical knowledge gained from real-world market conditions forms the foundation of his current work.
For many years, he shared this extensive experience with investors as an active trader and author of various stock market services. In addition to his writing work, he advised financial firms on portfolio management and established himself as an expert in modern market analysis.
His technical understanding extends far beyond traditional chart analysis: He develops fully automated trading systems as well as customized stock screeners that systematically identify market opportunities based on quantitative criteria. These algorithmic tools cover a broad spectrum ranging from stocks to futures and foreign exchange (FX) trading. They exemplify his holistic, technology-driven approach, which he now incorporates into his market reports as a business journalist and analyst.
Commented by Matthias Schomber
Commented by Matthias Schomber on October 30th, 2026 | 05:27 CET
BioNTech seeks a breakthrough with its cancer pipeline, DroneShield battles short sellers and Cardiol Therapeutics targets a rebound!
Created and published on behalf of Cardiol Therapeutics
Biotech heavyweights such as BioNTech and defence and drone stocks such as DroneShield are currently looking for unambiguous and clear trend signals. While BioNTech is grappling with clinical setbacks and internal discussions despite strategic collaborations, defence specialist DroneShield is weighed down by persistent short-selling pressure and rather subdued growth expectations. At the same time, Cardiol Therapeutics is coming into focus as a technically promising candidate that, following a correction lasting several months, could now find the long-awaited bottom at a prominent technical support zone. This equity analysis of the 3 stocks examines the financial data, operational milestones and strategic opportunities as well as the risks of the three companies to provide guidance that is as well-founded as possible. Read on to find out where attractive opportunities are now emerging.
Read
Commented by Matthias Schomber on October 29th, 2026 | 05:24 CET
Space, Tickets and Mustard Seed Power: A Stock Rally Ahead? Why OHB, CTS Eventim and MustGrow Biologics Could Be Set for a Boost
Created and Published on Behalf of MustGrow Biologics Corp.
Aerospace group OHB stands out with a strategic stake and a full order book, while ticketing specialist CTS Eventim is attracting fresh attention after an activist US investor entered. An interesting company to watch, however, is MustGrow Biologics. The cleantech company's "Fireside Chat" with Bayer yesterday may have provided important impetus. After months of consolidation, the stock could now be poised for a breakout. If it breaks above key resistance levels, significant potential awaits.
Commented by Matthias Schomber on October 28th, 2026 | 05:33 CET
Targeting Billion-Dollar Markets: Why Novo Nordisk, Airbus and HPQ Silicon Offer Surprising Opportunities Despite Headwinds
Created and Published on Behalf of HPQ Silicon
The stock market has been highly turbulent throughout the year. Consider the hype around memory and chip stocks. Other sectors, such as real estate, have been hit hard by high interest rates and talk of potential expropriations in Berlin. Backing the wrong horse can quickly prove costly. This autumn's market environment is once again testing investors' nerves. The wars in Ukraine and Iran, high oil prices, riots in Paris, Milan, Tirana and other cities, and surging bond yields in countries such as France continue to fuel uncertainty. While weight-loss specialist Novo Nordisk fights to defend market share and deliver fresh clinical successes, aerospace group Airbus faces the mammoth task of a record-breaking year-end push. Meanwhile, silicon pioneer HPQ Silicon is waiting in the wings for its moment in the spotlight. Its shares could be approaching a technical turning point. Our analysis examines the key figures, outlines the risks and, above all, highlights the opportunities these three exciting stocks offer.
Commented by Matthias Schomber on October 23rd, 2026 | 05:42 CEST
Puma Boardroom Shake-Up, Margin Pressure at BYD and Clinical Milestones at BioNxt Solutions
Sportswear manufacturer Puma is pressing ahead with its strategic realignment following a change of ownership and the arrival of Anta Sports as a shareholder. Chinese electric vehicle group BYD is grappling with regulatory hurdles and declining export margins. In the advanced drug delivery segment, BioNxt Solutions is attracting investors' attention with clinical progress and an interesting chart pattern. This article analyses the opportunities and risks of these three stocks. A close look at their fundamentals and technicals shows where key entry and turning points could lie for investors in the coming days and weeks.
Read
Commented by Matthias Schomber on October 23rd, 2026 | 05:22 CEST
Structural Crisis, Fears of Expropriation and Resource Potential: The Hard Truth About Deutz, Vonovia and Strategic Resources
Deutz and Vonovia are still grappling with structural challenges, radical proposals for expropriation and mounting interest burdens. Meanwhile, some investors are looking beyond the usual market favourites for new perspectives. Critical minerals needed to decarbonise heavy industry are attracting growing attention, with developments that may not yet be fully recognised by the broader market. In this article, we examine Strategic Resources' research collaborations in Northern Europe and potential technical turning points on the charts. Read on to explore the challenges facing these companies, the developments shaping their outlooks and the factors that could influence their future performance.
Read
Commented by Matthias Schomber on October 22nd, 2026 | 08:02 CEST
Zefiro Methane Surges! Conquering a Huge Market! The Next Success Story Is Taking Shape!
Created and Published on Behalf of Zefiro Methane Corp.
Abandoned oil and gas wells that release climate-damaging methane into the atmosphere unnoticed were long regarded as an almost insoluble environmental problem in the US. Today, these historical liabilities are becoming lucrative future markets thanks to stricter guidelines and massive government infrastructure programmes. One pioneer is North American service provider Zefiro Methane, which boasts years of industry experience and a full order book. After a rapid share price rally, followed by a swift, healthy correction, investors are watching the current technical chart setup with anticipation, and it looks good. The combination of government contracts worth millions and strong operational capacity utilisation makes the stock a promising investment case for many investors. Read on to explore Zefiro Methane's growth opportunities in the methane reduction market and the key operational developments to watch.
Read
Commented by Matthias Schomber on October 22nd, 2026 | 05:21 CEST
thyssenkrupp's Steel Restructuring, AI-Driven Cost Savings at Deutsche Telekom and a Potential Rebound for Almonty
thyssenkrupp is pushing ahead with its long-awaited steel restructuring, while Deutsche Telekom aims to digitise its domestic market through major fibre-optic and automation projects. After decades, Almonty Industries is celebrating the historic resumption of tungsten production, but is currently navigating a challenging consolidation phase that could now give way to a rebound. This report examines the facts, weighs the opportunities and risks, and identifies where attractive entry points may be emerging.
Read
Commented by Matthias Schomber on October 19th, 2026 | 05:33 CEST
Between Defence Stocks and the Gold Rush: Rheinmetall, Hensoldt and Lahontan Gold Could Become Profit Machines
The defence sector has recently been surging. These are uncertain times, shaped by wars and the resulting military build-up. With interest rates and inflation also rising, the environment is favourable for gold. While European defence heavyweights benefit from rising defence budgets and carry order backlogs worth billions, a smaller gold explorer is seeking to impress with hard facts and compelling PEA figures. In this comprehensive analysis, we examine three leading companies with one thing in common: they operate in sectors attracting considerable attention in the current environment. We look at the key factors shaping Rheinmetall and Hensoldt's market performance, where the hidden risks lie, and why Lahontan Gold's revised PEA could offer new insight into the project's development.
Read
Commented by Matthias Schomber on October 15th, 2026 | 05:21 CEST
Where Is the Perfect Entry Point? Porsche AG, Aixtron and Power Metallic Mines Put to the Test
Porsche AG is struggling with a noticeable sales decline and is trying to push through its strategic reforms. Despite a nervous market environment, semiconductor equipment manufacturer Aixtron is attracting attention, supported by strong tailwinds from AI infrastructure, and is making a clear statement. Meanwhile, Power Metallic Mines is emerging as an interesting resources stock that, after a recent consolidation and backed by high-grade polymetallic deposits, could be poised for a rebound. In this report, we examine the operational milestones, current analyst assessments and opportunities and risks for these three stocks. Read on to find out which companies are making a compelling case, where investors should look closely, and which stocks deserve a place on the watchlist, or even in the portfolio.
Read
Commented by Matthias Schomber on October 14th, 2026 | 05:38 CEST
Nel ASA, Plug Power and dynaCERT: Who Will Achieve the Hydrogen Breakthrough? There is Interesting News!
Is the hydrogen sector finally poised for a turnaround, or will investors continue to burn through their savings? While industry heavyweights Nel ASA and Plug Power grapple with pending major orders and lingering questions about profitability, an often-overlooked stock is attracting attention with tangible progress. We take a closer look at three companies to assess which could outperform.
Read